BRPI0818450A2 - Antagonistas do receptor de 5-ht7 - Google Patents

Antagonistas do receptor de 5-ht7

Info

Publication number
BRPI0818450A2
BRPI0818450A2 BRPI0818450A BRPI0818450A2 BR PI0818450 A2 BRPI0818450 A2 BR PI0818450A2 BR PI0818450 A BRPI0818450 A BR PI0818450A BR PI0818450 A2 BRPI0818450 A2 BR PI0818450A2
Authority
BR
Brazil
Prior art keywords
receptor antagonists
migraine
formula
treatment
present
Prior art date
Application number
Other languages
English (en)
Inventor
Valentina O Badescu
Sandra Ann Filla
Peter Thaddeus Gallagher
Maria Ann Whatton
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BRPI0818450A2 publication Critical patent/BRPI0818450A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0818450 2007-10-12 2008-09-30 Antagonistas do receptor de 5-ht7 BRPI0818450A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97946407P 2007-10-12 2007-10-12
PCT/US2008/078294 WO2009048765A1 (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists

Publications (1)

Publication Number Publication Date
BRPI0818450A2 true BRPI0818450A2 (pt) 2015-05-12

Family

ID=40134870

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818450 BRPI0818450A2 (pt) 2007-10-12 2008-09-30 Antagonistas do receptor de 5-ht7

Country Status (19)

Country Link
US (1) US7910588B2 (pt)
EP (1) EP2201002B1 (pt)
JP (1) JP5291716B2 (pt)
KR (1) KR101161070B1 (pt)
CN (1) CN101821257B (pt)
AT (1) ATE548365T1 (pt)
AU (1) AU2008311154B2 (pt)
BR (1) BRPI0818450A2 (pt)
CA (1) CA2699674C (pt)
CY (1) CY1112709T1 (pt)
DK (1) DK2201002T3 (pt)
EA (1) EA016787B1 (pt)
ES (1) ES2380756T3 (pt)
HR (1) HRP20120257T1 (pt)
MX (1) MX2010003986A (pt)
PL (1) PL2201002T3 (pt)
PT (1) PT2201002E (pt)
SI (1) SI2201002T1 (pt)
WO (1) WO2009048765A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI396857B (zh) * 2009-12-30 2013-05-21 Etron Technology Inc 晶片測試電路
JP2014528462A (ja) 2011-10-11 2014-10-27 ユセベ ファルマ ソシエテ アノニム 2−オキソ−ピペリジニル誘導体
US9802924B2 (en) 2013-03-11 2017-10-31 Temple University Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
TW201601632A (zh) * 2013-11-20 2016-01-16 杜邦股份有限公司 1-芳基-3-烷基吡唑殺蟲劑
EP3200589A4 (en) 2014-09-10 2018-07-25 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US10858368B2 (en) 2016-11-15 2020-12-08 Temple University—Of the Commonwealth System of Higher Education Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
MA49017A (fr) 2017-03-21 2020-02-05 Univ Temple Modulateurs du récepteur 7 de la 5-hydroxytryptamine et utilisation de ces derniers en tant qu'agents thérapeutiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US20030008880A1 (en) 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
CA2514656A1 (en) * 2003-01-31 2004-08-12 Pfizer Products Inc. 5ht7 antagonists and inverse agonists
US7211783B2 (en) 2004-01-09 2007-05-01 Tamperproof Container Licensing Corp. Tamper-proof container
US7820817B2 (en) 2004-05-28 2010-10-26 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
TW200914020A (en) * 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Also Published As

Publication number Publication date
PL2201002T3 (pl) 2012-07-31
ES2380756T3 (es) 2012-05-18
CY1112709T1 (el) 2016-02-10
SI2201002T1 (sl) 2012-04-30
KR101161070B1 (ko) 2012-07-13
MX2010003986A (es) 2010-04-27
US7910588B2 (en) 2011-03-22
DK2201002T3 (da) 2012-04-10
EA201070462A1 (ru) 2010-10-29
JP2011500575A (ja) 2011-01-06
EP2201002B1 (en) 2012-03-07
PT2201002E (pt) 2012-04-27
JP5291716B2 (ja) 2013-09-18
AU2008311154A1 (en) 2009-04-16
CN101821257A (zh) 2010-09-01
ATE548365T1 (de) 2012-03-15
EP2201002A1 (en) 2010-06-30
EA016787B1 (ru) 2012-07-30
CA2699674A1 (en) 2009-04-16
WO2009048765A1 (en) 2009-04-16
CA2699674C (en) 2013-07-16
KR20100054853A (ko) 2010-05-25
HRP20120257T1 (hr) 2012-04-30
US20100197700A1 (en) 2010-08-05
AU2008311154B2 (en) 2013-09-26
CN101821257B (zh) 2013-05-22

Similar Documents

Publication Publication Date Title
ATE394400T1 (de) Bicyclische anilidspirohydantoine als cgrp- rezeptorantagonisten
ATE537170T1 (de) Cgrp-rezeptorantagonisten
MX2013005246A (es) Antagonistas del receptor del peptido relacionado con el gen de calcitonina (cgrp) de piperidinona carboxamida azaindano.
CY1112709T1 (el) Ανταγωνιστες υποδοχεα 5-ητ7
ATE411323T1 (de) Cgrp-rezeptorantagonisten
ATE556060T1 (de) Monocyclische anilidspirohydantoine als cgrp- rezeptorantagonisten
JO2355B1 (en) Hereditary calcitonin polypeptide receptor antagonists
ATE516803T1 (de) Aryl-spirohydantoin-cgrp-rezeptor-antagonisten
ATE493412T1 (de) Spirohydantoin-aryl-cgrp-rezeptorantagonisten
BRPI0514736A (pt) inibidores do receptor sigma
ATE533762T1 (de) Chinolin- oder isochinolinsubstituierte p2x7- antagonisten
ATE535514T1 (de) Carboxamid-spirohydantoin-cgrp-rezeptor- antagonisten
TW200608960A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
DE602005027230D1 (de) Cgrp-rezeptorantagonisten
ATE466853T1 (de) Cgrp-rezeptorantagonisten
ATE542795T1 (de) Benzylpiperazinderivate als motilin- rezeptorantagonisten
TW200734323A (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
DE602005027870D1 (de) Cgrp-rezeptorantagonisten
EA201070599A1 (ru) Ингибиторы равновесного переносчика нуклеозидов ent1
MA33059B1 (fr) Utilisation d'antagonistes des recepteurs nk
MA32224B1 (fr) Derives de (pyrazolyl-carbonyl) imidazolidinone pour le traitement de maladies retrovirales
BR112012014235A2 (pt) tiazóis bicíclicos como moduladores alostéricos de receptores mglur5
PT1497292E (pt) Derivados de azaindolilpiperidina como agentes anti-histaminicos e antialergicos
EA200802104A1 (ru) Применение композиций, содержащих антагонисты каппа-опиоидных рецепторов, для лечения диссоциативных расстройств

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time